Chinese Creat Group's takeover of Germany's Biotest faces increased U.S. scrutiny

Chinese investor Creat Group Corp.’s planned takeover of German blood plasma supplier Biotest AG is facing increased scrutiny from the U.S. government, according to people familiar with the matter, potentially putting the deal at risk.